- Home
- CNMD vs IMNM Comparison
CNMD vs IMNM Comparison
Compare CNMD & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- IMNM
- Stock Information
- Founded
- CNMD 1970
- IMNM 2006
- Country
- CNMD United States
- IMNM United States
- Employees
- CNMD N/A
- IMNM N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- CNMD Health Care
- IMNM Health Care
- Exchange
- CNMD Nasdaq
- IMNM Nasdaq
- Market Cap
- CNMD 1.5B
- IMNM 1.2B
- IPO Year
- CNMD 1987
- IMNM 2020
- Fundamental
- Price
- CNMD $42.05
- IMNM $17.16
- Analyst Decision
- CNMD Hold
- IMNM Strong Buy
- Analyst Count
- CNMD 5
- IMNM 9
- Target Price
- CNMD $54.00
- IMNM $24.89
- AVG Volume (30 Days)
- CNMD 472.3K
- IMNM 1.4M
- Earning Date
- CNMD 11-05-2025
- IMNM 11-06-2025
- Dividend Yield
- CNMD 1.90%
- IMNM N/A
- EPS Growth
- CNMD N/A
- IMNM N/A
- EPS
- CNMD 2.05
- IMNM N/A
- Revenue
- CNMD $1,347,470,000.00
- IMNM $9,679,000.00
- Revenue This Year
- CNMD $6.73
- IMNM N/A
- Revenue Next Year
- CNMD $5.45
- IMNM $85.36
- P/E Ratio
- CNMD $20.51
- IMNM N/A
- Revenue Growth
- CNMD 4.61
- IMNM N/A
- 52 Week Low
- CNMD $41.41
- IMNM $5.15
- 52 Week High
- CNMD $78.00
- IMNM $18.46
- Technical
- Relative Strength Index (RSI)
- CNMD 33.75
- IMNM 59.97
- Support Level
- CNMD $42.80
- IMNM $14.64
- Resistance Level
- CNMD $45.55
- IMNM $17.94
- Average True Range (ATR)
- CNMD 1.73
- IMNM 1.21
- MACD
- CNMD -0.19
- IMNM -0.05
- Stochastic Oscillator
- CNMD 9.96
- IMNM 67.63
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.